QA: Akorn INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2018_Akorn_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 730,151,000
1 IntangibleAssetsNetIncludingGoodwill 854,794,000
2 PropertyPlantAndEquipmentNet 313,418,000
3 remainder_Assets 11,148,000
4 LiabilitiesCurrent 171,089,000
5 LiabilitiesNoncurrent 907,177,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 346,844,947
8 SellingGeneralAndAdministrativeExpense 258,743,826
9 ResearchAndDevelopmentExpense 176,270,321
10 remainder_Expenses 79,151,078
11 remainder_Revenues 487,895,442
12 remainder_NetIncome -35,245,440
13 remainder_ComprehensiveNetIncome 2,740,075
  yvar yval
0 Assets 1,909,511,000
1 Liabilities 1,078,266,000
2 Expenses 861,010,172
3 Revenues 487,895,442
4 StockholdersEquity 831,245,000
5 NetIncome -408,360,170
6 ComprehensiveNetIncome -406,990,132
7 BaseVar 2,187,334,064
8 EconomicCapitalRatiobeforeLimitedLiability 0.941
9 EconomicCapitalRatio 2.25

Edgar->Model Mapping

Feature Distribution

Change over Time